title: Thalidomide: an old drug with new action.
abstract: Thalidomide is a drug that, since its development, has made history in the world of medicine--having been withdrawn and now has returned with a boom as an anticancer and immunomodulatory drug. However, its mode of action in various diseases (i.e. different types of hematologic malignancies, solid tumors) as well as in various infections (i.e. pneumonia, tuberculosis, HIV infection etc.) and related inflammatory conditions is not well understood. As the immune system plays an important role in the pathogenesis of both infection-related as well as noninfectious (i.e. cancer) inflammatory diseases, much research has been done in the past few years to discover and design better immunomodulatory agents. Such immunomodulatory agents should be able to target the immune system in such a way that host suffers minimum damage and normal function of the immune system remains intact. In the present review an attempt is made to highlight the immunomodulatory action of thalidomide in various pathologic conditions.
authors.affiliation: Department of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. vij_tox@yahoo.com
authors.forename: V
authors.initials: V
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Chhibber
mesh_terms: D000818:Animals; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use*; D013792:Thalidomide / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D013792:Thalidomide